The Additional Role of F18-FDG PET/CT in Characterizing MRI-Diagnosed Tumor Deposits in Locally Advanced Rectal Cancer
Tomography · 2024
DOI: 10.3390/tomography10040048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tomography, 2024. Verfasst von Mark J Roef und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands. Hauptthemen laut MEDLINE: Rectal Neoplasms, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Magnetic Resonance Imaging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rationale
F18-FDG PET/CT may be helpful in baseline staging of patients with high-risk LARC presenting with vascular tumor deposits (TDs), in addition to standard pelvic MRI and CT staging.
Methods
All patients with locally advanced rectal cancer that had TDs on their baseline MRI of the pelvis and had a baseline F18-FDG PET/CT between May 2016 and December 2020 were included in this retrospective study. TDs as well as lymph nodes identified on pelvic MRI were correlated to the corresponding nodular structures on a standard F18-FDG PET/CT, including measurements of nodular SUVmax and SUVmean. In addition, the effects of partial volume and spill-in on SUV measurements were studied.
Results
A total number of 62 patients were included, in which 198 TDs were identified as well as 106 lymph nodes (both normal and metastatic). After ruling out partial volume effects and spill-in, 23 nodular structures remained that allowed for reliable measurement of SUVmax: 19 TDs and 4 LNs. The median SUVmax between TDs and LNs was not significantly different (p = 0.096): 4.6 (range 0.8 to 11.3) versus 2.8 (range 1.9 to 3.9). For the median SUVmean, there was a trend towards a significant difference (p = 0.08): 3.9 (range 0.7 to 7.8) versus 2.3 (range 1.5 to 3.4). Most nodular structures showing either an SUVmax or SUVmean ≥ 4 were characterized as TDs on MRI, while only two were characterized as LNs.
Conclusions
SUV measurements may help in separating TDs from lymph node metastases or normal lymph nodes in patients with high-risk LARC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Nuclear Medicine, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.
- Catharina Cancer Institute, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.
- Department of Surgery, Catharina Hospital Eindhoven, 5623 EJ Eindhoven, The Netherlands.
ORCID-Profile: Mark J Roef, Joost Nederend
Zitieren
APA
Roef, M. J., van den Berg, K., Rutten, H. J. T., Burger, J., & Nederend, J. (2024). The Additional Role of F18-FDG PET/CT in Characterizing MRI-Diagnosed Tumor Deposits in Locally Advanced Rectal Cancer. Tomography. https://doi.org/10.3390/tomography10040048
Vancouver
Roef MJ, van den Berg K, Rutten HJT, Burger J, Nederend J. The Additional Role of F18-FDG PET/CT in Characterizing MRI-Diagnosed Tumor Deposits in Locally Advanced Rectal Cancer. Tomography. 2024. doi:10.3390/tomography10040048
BibTeX
@article{Roef2024,
author = {Roef, Mark J and van den Berg, Kim and Rutten, Harm J T and Burger, Jacobus and Nederend, Joost},
title = {The Additional Role of F18-FDG PET/CT in Characterizing MRI-Diagnosed Tumor Deposits in Locally Advanced Rectal Cancer},
journal = {Tomography},
year = {2024},
doi = {10.3390/tomography10040048}
}
EUVIMED